Impact of Dynamic Neuromuscular Stabilization on Pregnancy Outcomes
The Effect of Dynamic Neuromuscular Stabilization Applied in the Second Trimester of Pregnancy on Pregnancy: A Randomized Controlled Study
NA · Lütfi Kırdar City Hospital · NCT06239753
This study tests if special exercises for muscle stability can help improve pregnancy and childbirth outcomes compared to regular prenatal education.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 144 (estimated) |
| Ages | 20 Years to 35 Years |
| Sex | Female |
| Sponsor | Lütfi Kırdar City Hospital (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06239753 on ClinicalTrials.gov |
What this trial studies
This randomized controlled study aims to evaluate the effects of Dynamic Neuromuscular Stabilization (DNS) on pregnancy and childbirth outcomes. It focuses on how DNS can help manage the anatomical and physiological changes that occur during pregnancy, which can lead to various complications. The study will compare the outcomes of participants who undergo DNS exercises with those who receive standard prenatal education. By addressing postural changes and strengthening pelvic floor muscles, the study seeks to improve overall pregnancy health.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women aged 20-35, in their first pregnancy, with a singleton pregnancy and a BMI between 18-30.
Not a fit: Patients with heart conditions, restrictive lung diseases, multiple pregnancies, severe anemia, or musculoskeletal anomalies may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved pregnancy outcomes and reduced complications for mothers.
How similar studies have performed: While there is limited research specifically on DNS during pregnancy, studies have shown that stabilization exercises can be more effective than traditional strength exercises in managing pregnancy-related complaints.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Primiparity * Singleton Pregnancy * Gestational Age Between 11-13 Weeks * Age Between 20-35 Years * Body Mass Index in the Range of 18-30 * Receiving Pregnancy Check-ups at the Hospital where the Research is Conducted Exclusion Criteria: * Presence of a heart condition affecting hemodynamics * History of restrictive lung disease * Multiple pregnancies * Severe anemia * Movement-restricting musculoskeletal system anomalies
Where this trial is running
Istanbul
- Lütfi Kırdar Şehir Hastanesi — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Principal investigator: Elif Ünlügedik Sayın, Dr. — KLKŞH
- Study coordinator: Döndü Kurnaz, Dr
- Email: zsk2001@hotmail.com
- Phone: 5052381105
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pregnant, Exercise, Pregnancy, Stabilization